Thu, Jul 18, 2024
Vonoprazan is a novel, orally active potassium competitive acid blocker (PCAB), used to treat reflux esophagitis and other acid peptic disorders.
More >
Tue, Jan 30, 2024
The company's consolidated revenue from operations also saw a rise of 7.05 per cent as it also beat analysts' estimates to rise to Rs 7237 crore in Q3 from Rs 6760 crore in the same quarter last fiscal. The revenue was above the research estimate of Rs 6914 crore.
Mon, Jan 29, 2024
Zee Business research estimates the pharma firm to report a five per cent jump in its consolidated profit after tax (PAT) to Rs 1310 crore in the December quarter against Rs 1247 crore in the same quarter last fiscal.
Mon, Dec 11, 2023
Dr. Reddy's Nifty's Top Losers...Dr. Reddy's touched 1 month low... Why did the stock fall?
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
